Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alfred Körfer"'
Autor:
Roberto Biasioli, Steven Piver, Martin Hadam, Giulio Vignati, Antonio Fortunato, Hafiz Ahmed, Marcella Gulisano, Anke Franzke, Iris Dallmann, Hartmut Kirchner, Hubert Poliwoda, Markus Deckert, Naomi Kondo, Ashu Sharma, Jens Grosse, Jens Atzpodien, Michael Kraus, Tadao Orii, Fumiaki Motoyoshi, Axel Schomburg, Matthias Volkenandt, Silvana Saracchini, Alfred Körfer, Howard J. Allen, Bernhard Wolf, Marie Gamarra, Thomas Menzel, Massimo Gion, Gino Cappelli, R Mione
Publikováno v:
Tumor Biology. 14:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::429e58e553c2633cabe1acc8fac1ae47
https://doi.org/10.1159/000217846
https://doi.org/10.1159/000217846
Autor:
Hubert Poliwoda, Carsten Schneekloth, Martin Hadam, Axel Schomburg, Thomas Menzel, Enrique Lopez Hänninen, Alfred Körfer, Hartmut Kirchner, Jens Atzpodien, Iris Dallmann
Publikováno v:
Acta Haematologica. 89:13-21
Phenotypic characterization of peripheral blood lymphocytes was performed in patients with advanced metastatic cancer receiving low-dose recombinant interleukin-2 (rIL-2) and recombinant interferon-alpha (rIFN-alpha) as subcutaneous home therapy. A t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d82e3158e5efcead56dbb0737fb08b
https://doi.org/10.1159/000204476
https://doi.org/10.1159/000204476
Autor:
Thomas Menzel, Hartmut Kirchner, Sabine Casper, Jens Atzpodien, Martin Hadam, Alfred Körfer, Axel Schomburg, Hubert Poliwoda, Iris Dallmann, Magdalena Meffert
Publikováno v:
Cancer Biotherapy. 8:199-212
High dose interleukin-2 alone or in combination with lymphokine activated killer (LAK) cells has demonstrated antitumor activity in a variety of malignant diseases. The currently formulated recombinant human interleukin-2 (IL-2) has limited solubilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e3acfcd8be9a2de4c35af7b36700c82
https://doi.org/10.1089/cbr.1993.8.199
https://doi.org/10.1089/cbr.1993.8.199
Autor:
Jens Atzpodien, Alfred Körfer, Klaus Resch, Pauline Evers, Martin Hadam, Ulrich Pohl, Harald Mohr, Hubert Poliwoda, Marta Szamel, Joseph Knüver-Hopf, Chris R. Franks, Hartmut Kirchner
Publikováno v:
Cancer. 67:1862-1864
Systemic administration of interleukin-2 (IL-2) in humans may induce antibodies specific to IL-2. The case is reported of a patient with metastatic rectal carcinoma who was treated with long-term subcutaneous IL-2 and a combination of subcutaneous IL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f74f397aa9f01606b5544e3f52fbbd84
https://doi.org/10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co
https://doi.org/10.1002/1097-0142(19910401)67:7<1862::aid-cncr2820670708>3.0.co
Autor:
Axel Schomburg, H. Kirchner, Anke Franzke, Matthias Volkenandt, Duensing S, Jens Atzpodien, Alfred Körfer, S. Chaitchik, H. Poliwoda, E. Lopez Hänninen
Publikováno v:
European journal of cancer (Oxford, England : 1990). (6)
Both chemotherapy and interleukin-2 and/or interferon-alpha produce objective responses in a proportion of advanced malignant melanoma patients. While duration of response to chemotherapy is short, i.e. usually below 4 months, immunotherapy has resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7357f127997e3481b141d12daaeffda
https://pubmed.ncbi.nlm.nih.gov/7646914
https://pubmed.ncbi.nlm.nih.gov/7646914
Autor:
Jens Atzpodien, Jens Grosse, Matthias Volkenandt, Martin Hadam, Alfred Körfer, Anke Franzke, Hubert Poliwoda, Markus Deckert, Iris Dallmann, Axel Schomburg, Hartmut Kirchner, Thomas Menzel
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 14(6)
Natural killer (NK) cells are believed to contribute to the clinical efficacy of cancer immunotherapy using recombinant interleukin-2 (rIL-2) in humans. In previous trials of high-dose i.v. rIL-2, however, no correlation has been established between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1ada193c883e645ae5e7228d84b8aa1
https://pubmed.ncbi.nlm.nih.gov/8265981
https://pubmed.ncbi.nlm.nih.gov/8265981
Autor:
Alfred Körfer, Johannes Meran, Mathias Freund, Simone Giller, Fokke Hinrichs, H. Link, Axel Baars, Hubert Poliwoda
Publikováno v:
Journal of cancer research and clinical oncology. 117(5)
Twenty-two patients with acute myeloid leukemia (AML), having a median age of 48.3 years (range 26–70; 10 male, 12 female), were treated with 4′-(9-acridinylamino)methanesulphon-m-anisidide (m-AMSA) 100 mg/m2 and cytosine arabinoside (AraC) 2×10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86dce527ef3a45300aaa538597d5af25
https://pubmed.ncbi.nlm.nih.gov/1890142
https://pubmed.ncbi.nlm.nih.gov/1890142
Autor:
Steven Piver, Howard J. Allen, Hubert Poliwoda, Fumiaki Motoyoshi, Ashu Sharma, R Mione, Roberto Biasioli, Tadao Orii, Naomi Kondo, Markus Deckert, Jens Atzpodien, Martin Hadam, Thomas Menzel, Hafiz Ahmed, Marcella Gulisano, Axel Schomburg, Bernhard Wolf, Jens Grosse, Marie Gamarra, Anke Franzke, Hartmut Kirchner, Giulio Vignati, Matthias Volkenandt, Alfred Körfer, Michael Kraus, Iris Dallmann, Antonio Fortunato, Gino Cappelli, Massimo Gion, Silvana Saracchini
Publikováno v:
Tumor Biology. 14:375-376
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bd91a6077d91372a96e116864c7d16b
https://doi.org/10.1159/000217854
https://doi.org/10.1159/000217854
Autor:
Christoph Bührer, Bayard D. Clarkson, Hubert Poliwoda, Subhash C. Gulati, Robert Knowles, David Wisniewski, Jens Atzpodien, Alfred Körfer, Carsten Schneekloth, Hartmut Kirchner
Publikováno v:
Acta Haematologica. 82:193-196
Using a modified alkaline-phosphatase/antialkaline-phosphatase method for phenotyping fresh human leukemias, we could demonstrate peripheral blood and bone marrow-derived blast cells to specifically react with two monoclonal antibodies (MoAbs), H25 a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a31adf605fecf15cb136a84b6f1d8b1
https://doi.org/10.1159/000205375
https://doi.org/10.1159/000205375
Autor:
F. Barbieri, Masakuni Sugimoto, Jens Atzpodien, Zalmen A. Arlin, Michael Andreeff, Shun-ichi Hirose, Manabu Hashimoto, Subhash C. Gulati, H.M. Cooke, Carsten Schneekloth, Yoshihisa Wakabayashi, Seiichi Horie, P. Bernasconi, Hubert Poliwoda, J.D. Norton, C. Kitchen, Hartmut Kirchner, M.J. Mestre, Warren G. Thompson, C. Bernasconi, Taijiro Ishiyama, M. Federico, Villarrubia Espinosa, G.P. Palomba, M.C. Ortiz-Conde, C. Castagnola, Harry Staszewski, Donald Colbourn, P.J. Browett, C. Mauri, Eric J. Feldman, Bayard D. Clarkson, Fernandez Fuertes, V.S. Silingardi, F.J. De la Serna, A. Garcia-Marcilla, Anton Hagenbeek, Christoph Bührer, M. Bonfichi, Sureda Balari, A. Colombo, Alfred Körfer, H.G. Prentice, J.I. Lopez, Michael L Freedman, David Wisniewski, Harold Ludman, L.M. Secker-Walker, A.G. Prentice, Robert Knowles, Virginia Donovan, A. Frassoldati
Publikováno v:
Acta Haematologica. 82:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8e86074f201d0310fc41f01024627af
https://doi.org/10.1159/000205370
https://doi.org/10.1159/000205370